Move Aside, Paper: Capturing Clinical Trial Outcomes in the Digital Age

The FDA wants to hear from patients directly during clinical trials. Their “Voice of the Patient” initiative gives the FDA a broader perspective on outcomes across many treatment areas. Technology is more important than ever for collecting valuable, accurate, timely information from patients.

In this article, you’ll learn about:

• The scientific realities of patient reporting
• Misconceptions about paper-based survey tools
• 8 keys to implementing electronic tools successfully
• The eCOA landscape
• How to choose the best solution

 Read this article now at http://bit.ly/almac-showcase

Risk or Reward? Collaboration and Social Media in the pharmaceutical Industry - white paper

Drug makers are just beginning to realize how collaboration and communication networks can improve business processes. But what seems like a spoon full of sugar is often a tough pill to swallow when you consider regulatory requirements from agencies like the FDA for use of these networks. This white paper provides an understanding of many of the regulatory and legal issues related to electronic communications and social media in the pharmaceutical industry.

Read this paper to gain an understanding of:
• What the regulatory landscape of the pharmaceuticals industry looks like
 • What concerns you should be aware of from a legal perspective

Download this free white paper now - Click Here

Provided by: Actiance